1) Warren JR, Marshall B:Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet i:1273-1275, 1983
2) NIH consensus development panel on Helicobacter pylori in peptic ulcer disease Helicobacter Pylori in peptic ulcer disease. JAMA 272:65-69, 1994
3) 日本消化器病学会 Helicobacter pylori 治験検討委員会:Helicobacter pylori 治験ガイドライン資料, 竹本忠良編, 1995
4) 日本ヘリコバクター学会ガイドライン作成委員会:Helicobacter Pylori 感染の診断と治療のガイドライン. 日本ヘリコバクター学会誌 2 (suppl):S1-S12, 2000
5) 日本ヘリコバクター学会ガイドライン作成委員会:Helicobacter Pylori 感染の診断と治療のガイドライン2003年改訂版. Helicobacter Res 7:253-265, 2003
6) 佐々木徹, 西元寺克禮, 樋口勝彦ほか:H. Pylori の感染経路と疫学. Surg Fronti 11:112-117, 2004
7) 藤岡利生, 香川二朗, 児玉雅明:Helicobacter Pylori 除菌療法の補助薬としてのプロトンポンプ阻害薬の意義. プロトンポンプ阻害薬のすべて, 浅香正博, 千葉勉編, 先端医学社, 東京, 2002, pp.180-184
8) Tytgat GNJ, Axon ATR, Dixon MF et al:Helicobacter pylori:casual agent in peptic ulcer disease?In:Working Party Reports of the VVorld Congress of Gastroen terology, Blackwell Scientific Publications, Melbourne, 1990, pp. 36-45
9) 佐藤貴一, 木平健, 瀧本拓哉ほか:Helicobacter pylori 除菌の世界の現状. Helicobacter Res 1:24-30, 1997
10) Bazzoli E Zagari M, Fossi S et al:Efficacy and tolerability of a short term, low dose triple therapy for eradication of Helicobacter pylori. Gastroenterology 104:A40 (abstract), 1993
11) M?graud F, Malfertheiner P:Treatment of Helicobacter pylori infection:summary of a meeting at the Fourth United European Gastroenterology Week, September 20, 1995. Helicobacter 1:118-121, 1996
12) Fujioka H, Ohkura R, Murai T et al:In vitro activity of novel proton pump inhibitors against Helicobacter pylori. In:Recent Advances in Chemotherapy eds. by Einhorn J et al, ASM, Washington DC, 1995, pp. 612-613
13) 林千鶴子, 坂上隆, 三輪洋人:除菌治療効果とPPI・H2RAの使い分け. 臨消内科 20:1193-1200, 2005
14) Sachs G, Shin JM, Munson K et al:Review article:the control of gastric acid and Helicobacter pylori eradication. Aliment Pharmacol Ther 14:1383-1401, 2000
15) Gustavson LE, Kaiser JE Edmonds AL et al:Effect of omeprazole on concentrations of clarithromycin in plasma and gastric tissue at steady state. Antimicrob Agents Chemother 39:2078-2083, 1994
18) Lind T, Veldhuyzen van Zanten S, Unge P et al:Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials:the MACH I Study. Helicobacter 1:138-144, 1996
20) Malfertheiner P, Bayerdorffer E, Diete U et al:The GU-MACH study:the effect of 1-week omeprazole triple therapy on Helicobacter pylori infection in patients with gastric ulcer. Aliment Pharmacol Ther 13:703-712, 1999
21) Zanten SJ, Bradette M, Farley A et al:The DU-MACH study:eradication of Helicobacter pylori and ulcer healing in patients with acute duodenal ulcer using omeprazole based triple therapy. Aliment Pharmacol Ther 13:289-295, 1999
22) Asaka M, Sugiyama T, Kato M et al:A multicenter, double-blind study on triple therapy with lansoprazole, amoxicillin and clarithromycin for eradication of Helicobacter Pylori in Japanese peptic ulcer patients. Helicobacter 6:254-261, 2001
23) 桑山肇, 吉田俊一, 中村武史ほか:オメプラゾール, アモキシシリン, およびクラリスロマイシンの3剤併用による Helicobacter pylori 除菌療法の第III相二重盲検比較試験. 第7回日本ヘリコバクター学会抄録集, 2001, p.155